Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CDER help wanted

  • News

Executive Summary

FDA launches a candidate search for the director position at the Center for Drug Research and Evaluation and will accept applications until Feb. 1, 2008. The job summary does not include mention of the need for the director to mend internal conflicts, which recently led FDA to hire consultants to improve CDER staff interactions (1"The Pink Sheet" Oct. 15, 2007, p. 13). FDA Deputy Commissioner Janet Woodcock is currently serving as acting director...

You may also be interested in...



FDA Hires Consultants To Ease Conflicts Between CDER Staff

FDA is bringing in outside consultants to help improve staff interactions and build leadership in the agency's Center for Drug Evaluation and Research

Podcast: Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space

Listen to expert perspectives from Tracey Parker, Vice President, Biometrics, Advanced Clinical and Rebecca Starkie, Senior Global Patient Engagement Director, Advanced Clinical on the recent history of DEI in clinical trials and the barriers to patient participation. Examine the key drivers that have influenced the development of diversity, equity, and inclusion programs for clinical trials.

Regeneron, Pfizer Tout Potential BCMA Bispecific Advantages At ASCO

Regeneron presented data for linvoseltamab, while Pfizer presented data for elranatamab, including in patients who previously received BCMA-directed therapy. 

Table

View full table

Tags:
Latest Headlines

BIO Notebook: Sanofi Hunts For Later-Stage Assets; Orphan Drug Sponsors Hunt For Legislative Fixes

EU Multistakeholder Project Aims To Give eConsent The ‘Place It Deserves’

EU Regulatory Reforms Mean Many Orphan Drug Producers Won’t Benefit From Incentives

Canada Proposes List Of ‘Critical Products’ & More Agile Regulation To Address Shortages

See All
UsernamePublicRestriction

Register

PS049091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By